GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (OTCPK:ACIXF) » Definitions » Purchase Of Investment

ACIXF (Acarix AB) Purchase Of Investment : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Acarix AB Purchase Of Investment?

Acarix AB's purchase of investment for the three months ended in Dec. 2024 was $0.00 Mil. It means Acarix AB spent $0.00 Mil on purchasing investments. Acarix AB's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Sep. 2024 ), Acarix AB spent the same money on purchasing investments in Dec. 2024 ($0.00 Mil).

Acarix AB Purchase Of Investment Historical Data

The historical data trend for Acarix AB's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acarix AB Purchase Of Investment Chart

Acarix AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Acarix AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Acarix AB Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acarix AB Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Acarix AB's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Acarix AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (OTCPK:ACIXF) » Definitions » Purchase Of Investment
Comparable Companies
OSTO:QLINEA OSTO:NOSA OSTO:SPEC OSTO:INTEG B OSTO:NEOLA OSTO:BOUL OSTO:ARCOMA NGM:MCLR OSTO:SCIB XSAT:REDS ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
ACARIX:Sweden 7AC:Germany
Address
World Trade Center Malmo, Jungmansgatan 12, Malmo, SWE, 211 19
Website
https://www.acarix.com
Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96 percent certainty.